NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/29/2024
Back to search
Official data from USPTO
XJPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
10/29/2024
Trademark type
Combined
Nice classes
5
Filing date
11/11/2023
Registration date
10/29/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/29/2024
Last transaction
10/29/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2003
First use in commerce
01/01/2003
Drawing code
3
Owner type
99
Owner location
Zhejiang,, CN
Examiner
MAHONEY, PAULA M
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a figure of a hexagon with a tapering flame-shaped design appearing upward from the base of the mark and into the center portion of the hexagon. To the right of the hexagon is the stylized wording "XJ PHARMA".
Holders and representatives
Holders
Zhejiang Xianju Pharmaceutical Co., Ltd.
Representatives
Yue (Robert) Xu Apex Attorneys at Law, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Hormones; Androgen preparations; Anesthetics for surgical and non-surgical use; Anti-inflammatories; Chemical reagents for medical purposes; Contraceptive preparations; Estrogen preparations; Inhalers for medical purposessold filled with pharmaceutical preparations for treating chronic obstructive pulmonary disease; Medicated ointments for treating dermatological conditions; Muscle relaxants; Nasal sprays for medical purposes; Oral contraceptives; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of lung diseaserhinitisintestinal diseaseautoimmune diseaseskin diseaseallergic disease; Pharmaceutical preparations for treating allergic rhinitis; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2024
GNRT
NON-FINAL ACTION E-MAILED
06/25/2024
CNRT
NON-FINAL ACTION WRITTEN
06/25/2024
DOCK
ASSIGNED TO EXAMINER
06/18/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2024
NWAP
NEW APPLICATION ENTERED
11/11/2023
Continuous trademark protection
Get notified about every new filing that threatens XJPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.